BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, May 14, 2024
See today's BioWorld Asia
Home
» Orbimed secures $325M fund to invest in China's, India's health care markets
To read the full story,
subscribe
or
sign in
.
Orbimed secures $325M fund to invest in China's, India's health care markets
Sep. 17, 2014
By
Kristine Yang
No Comments
HONG KONG – The world's largest health care-dedicated investment firm, Orbimed, has secured a $325 million pan-Asia fund to invest in health care markets in the region, particularly in China and India.
BioWorld Asia